GL Capital Group
Beijinggl-investment.com
Overview
GL Capital Group is a private equity firm founded in 2010 that specializes in buyout and growth strategy investments within the healthcare sector in China.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sangon Biotech (Shanghai) Co., Ltd. | Aug 2023 | Strategic | Lead |
| ImmunOs Therapeutics | Jun 2022 | Series B | Co-investor |
| Wuxi NEST Biotechnology Co., Ltd. | Jun 2022 | Series A | Lead |
| Duoning Biotechnology | Nov 2021 | Series C | Co-investor |
| Hzymes Biotechnology Co., Ltd. | Nov 2021 | Series C | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?